A prescription drug benefit for Medicare beneficiaries has been hotly debated in the U.S. Congress for many years. Recent focus on a prescription drug benefit in the 107th Congress highlights the complexity of this partisan debate.
Get full access to this article
View all access options for this article.
References
1.
Carey, M. A. (2002a). Business and society: Parties pushing competing drug plans but small steps on Medicare most likely. Congressional Quarterly, 60(20), 1152-1153.
2.
Carey, M. A. (2002b). Business and society: Much variety, little traction, in Medicare drug plans. Congressional Quarterly, 60(28), 1848-1856.
3.
Carey, M. A. (2002c). Business and society: Medicare deal is possible, as senate studies bipartisan plan. Congressional Quarterly. 60(30), 2042-2046.
4.
Dewar, H., & Goldstein, A. (2002, July 28). Democrats trim prescription drug plans. The Washington Post, p. A6.
5.
Moon, M., & Storegard, M. (2002, August). Policy brief: Stretching federal dollars: Policy trade-offs in designing a Medicare drug benefit with limited resources. The Commonwealth Fund, pp. 1-8.
6.
The Commonwealth Fund. News Release. New York (NY). August 1, 2002.
7.
The Henry J. Kaiser Family Foundation. (2002). Prescription drug coverage for Medicare beneficiaries: A side-by-side comparison of selected proposals (Prepared by Health Policy Alternatives, Inc.). Washington, DC: Author.
